Page 207 - Genentech News Today

Basel, 2 February 2023 Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division sales increase

What makes life sciences companies like Gilead so attractive in our evolving economy is the degree to which they rely on in-person work to succeed

The global Cytokine Release Syndrome Management Market is expected to be worth US$ 23.32 billion in 2023, growing at a 6.7% CAGR between 2023 and 2033. In the coming years, the market for CRS management is expected to grow due to an increase in the number of autoimmune diseases and cancers.The development of novel t...

Basel, 2 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Board of Directors has made the following appointments: Teresa Graham, currently Head of Global Product Strategy

Recode Therapeutics Expands Leadership Team with Appointment of April Loui as Senior Vice President of Quality and CMC Regulatory Affairs - read this article along with other careers information, tips and advice on BioSpace

Technology companies and start-ups are familiar with protecting inventions with patents, and protecting their secret formulas, source code, and algorithms as trade secrets. But tech...

Plasmids are an important starting material for the manufacturing of mRNA- and cell-based drugsThe new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in... | February 2, 2023

AC Immune to Present at the SVB Securities Global Biopharma Conference Lausanne, Switzerland, February 2, 2023 - AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering

Plasmids are an important starting material for the manufacturing of mRNA- and cell-based drugsThe new plasmid manufacturing facility aims to increase BioNTech's autonomy and flexibility in manufacturing

A study by scientists at MIT and at the Broad Institute of MIT and Harvard shows how brain cells located near amyloid plaques and tau tangles change as Alzheimer’s disease progresses. The technique, called STARmap PLUS, is the first to simultaneously map gene expression of individual cells and their location, as well as the spatial distribution of specific proteins in intact tissue samples.